X4 Pharmaceuticals (XFOR) Gross Profit (2024 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly Gross Profit came in at $2.2 million in Q4 2025, up 94.7% YoY from $1.1 million in Q4 2024, and up 55.87% on a QoQ basis from $1.4 million in Q3 2025.
X4 Pharmaceuticals (XFOR) Gross Profit (2024 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 2 years of Gross Profit data on file, last reported at $2.2 million in Q4 2025.
- Quarterly Gross Profit rose 94.7% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.4 million (up 1567.95% YoY) and the FY2025 annual result came in at $29.4 million, up 1567.95% from the prior year.
- Gross Profit climbed to $2.2 million in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $24.1 million in Q1 2025 to a low of $295000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Jun 30, 2026 | 7.19 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 24.09 Mn |
| Mar 31, 2025 | 24.09 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 333,000.00 |
| Sep 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 295,000.00 |
| Jun 30, 2024 | 295,000.00 |